| # | Drug | Count |
|---|---|---|
| 0 | HYDROXYCHLOROQUINE | 15 |
| 1 | AZATHIOPRINE | 14 |
| 2 | MYCOPHENOLATE MOFETIL | 13 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 13 |
| 4 | CYCLOPHOSPHAMIDE | 11 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 11 |
| 7 | METHYLPREDNISOLONE | 11 |
| 8 | RITUXIMAB | 9 |
| 9 | PREDNISOLONE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IVABRADINE | 4 | 0.0006 |
| 1 | ISOSORBIDE MONONITRATE | 6 | 0.0003 |
| 2 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 3 | MILNACIPRAN HYDROCHLORIDE | 1 | 0.0002 |
| 4 | AZATHIOPRINE | 14 | 0.0002 |
| 5 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 6 | VOCLOSPORIN | 1 | 0.0001 |
| 7 | ISOSORBIDE DINITRATE | 2 | 0.0001 |
| 8 | MYCOPHENOLATE MOFETIL | 13 | 0.0001 |
| 9 | BELIMUMAB | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Purine Antimetabolite [EPC] | 14 | 0.0001 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Nitrate Vasodilator [EPC] | 7 | 0.0001 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 5 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 11 | 0.0000 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 10 | 0.0000 |